Nuclear Medicine Europe

The Nuclear Medicine Europe LinkedIn page has reached 5,000 followers, a significant milestone driven entirely by organic growth since the launch of this page during the pandemic. Let's take this opportunity to share some key insights and facts about our association through some facts and figures. Who are the followers of this page? • 32% are from Hospitals, Medical Practices, and Healthcare professionals • 19% come from Pharmaceutical and Medical Equipment Manufacturing • 10% represent Researchers and Biotechnology professionals • 30% of our followers are involved in #nuclearmedicine healthcare services and are directly in contact with patients. Over the years, we have produced several patient-centred animations, which are now used globally by hospitals, clinics, and physicians. Since making these resources available on YouTube (after years of being only available on the website), they have been viewed 375,000 times, representing more than 1.3 million minutes of watch time (equivalent to 22,000 hours, or 900 days). Today, Nuclear Medicine Europe has 60 members, with the latest addition being PHSE, further expanding our collaboration network. Explore all of our members by visiting this page: https://lnkd.in/dUBtDKxx Since our inception in 1987, our organization has been dedicated to supporting #healthcare #innovation and collaboration, and we are proud to mark 37 years of continued service being the voice of the industry. The Nuclear Medicine Europe logo holds deeper significance, reflecting the references, values and mission of our organization. See the logo breakdown in the comments. And finally, this Thursday, 10 October, at 10 AM CET 🗓️📢✨, we will reveal exciting news about Nuclear Medicine Europe's latest communication project right here. Our newsletter readers have already had an exclusive preview of this innovative tool, designed to benefit the entire nuclear medicine community. Don’t miss out—tune in!

Last week, the EANM was represented by our President Elect Paola Anna Erba at the 21st Plenary Meeting of the European Observatory on the Supply of Medical Radioisotopes, held at the European Organization for Nuclear Research (#CERN) in Geneva 🇨🇭. This event brought together key stakeholders to address critical topics, including: 🔸 Security of medical radioisotopes 🔸 Global supply monitoring 🔸 Initiatives to prevent shortages of medicinal products The discussions reflected a strong political commitment and shared determination among all participants to achieve one goal: ensuring timely access to radiopharmaceuticals for all patients. Attendees also had the opportunity to tour the ISOLDE and MEDICIS facilities, both advancing medical research by producing novel radioisotopes. A big thank you to the Euratom Supply Agency, Nuclear Medicine Europe, PRISMAP Project, and CERN for making this insightful meeting possible! 🤝

Nuclear Medicine Europe was informed by NRG, the operator of the HFR reactor, that a planned inspection on September 17th identified increased pipe deformation in the reactor’s primary system. Although repairs were originally set for December 2024, the issue must now be addressed before HFR cycle 2024-07 begins on October 10th. A solution is in place, and testing is ongoing. NRG aims to start the reactor one week later than planned, depending on the results of this week’s tests. Nuclear Medicine Europe anticipates potential Mo-99 shortages by mid-October and is actively exploring solutions to minimize delays, with strong support from the Security of Supply Working Group and the Emergency Response Team. Read the full statement below. Further updates will be provided soon.

The 21st Plenary Meeting of the European Observatory on the Supply of Medical #Radioisotopes has officially commenced at CERN in Switzerland. This European Observatory is a collaborative initiative between the Euratom Supply Agency and Nuclear Medicine Europe (https://lnkd.in/d7u2mjaV). Today's session will feature expert presentations from CERN's radioisotope specialists, an update on the Nuclear Medicine Europe activities by Konrade von Bremen, along with updates from Orano and key organizations such as the European Association of Nuclear Medicine (EANM), Euratom Supply Agency, PRISMAP Project, as well as SAMIRA/ERVI among others. Tomorrow, participants will take part in a technical visit to ISOLDE, MEDICIS, and the CERN Science Gateway. A detailed update of the visit will follow soon.

Nuclear Medicine Europe is happy to sponsor the Oncidium foundation in their 2024 The Tackle Cancer Challenge, a global event created to raise awareness about #Radiotheranostics in #CancerCare 🎗️. You can join the challenge from anywhere in the world, registration for the 3rd edition of #TackleCancerChallenge is open : https://lnkd.in/eF4CuAaS #CancerAwareness #Oncidiumfoundation

Exciting News from Nuclear Medicine Europe! 🚀 Over the summer, we have been hard at work on a major project that aims to benefit the entire #nuclearmedicine community. Whether you're one of our industry partners and friends, academics, physicians, or patients, this project has something valuable for you. Our goal is not only to provide practical tools and insights but also to raise awareness about the benefits of nuclear medicine. We’re putting the final touches on it, but for those of you who are curious, we’ve already left a hint on one of our related platforms. The official presentation will take place next month during the European Association of Nuclear Medicine (EANM) Annual Congress in Hamburg, and we can't wait to share it with all of you. Stay tuned for more updates very soon! #awareness #radiopharma #isotopes #radioisotopes

As we have just sent out the latest issue and many of you are returning from summer break, we want to remind you that Nuclear Medicine Europe has exceptionally offered the entire #nuclearmedicine community access to their member-only Selected Industry News. Download three issues of our newsletter for free, to catch up on the most important #marketing and #clinical news from the last two months : https://lnkd.in/d6g7i9RJ

To help the entire #NuclearMedicine community catch up on the latest #market and #clinical updates that have happened during the summer break, Nuclear Medicine Europe exceptionally offers free access to the last three issues of the "Selected Industry News", the bi-monthly, members-only #newsletter. No registration, no email collection—just straightforward, free access. Download these issues now : https://lnkd.in/d6g7i9RJ Happy reading!

Today, we celebrate Martinus Blauwhoff's remarkable work anniversary, marking 40 years of dedication and commitment to the #nuclearmedicine field. His exceptional expertise has been, and, as President of Nuclear Medicine Europe, still is invaluable to our association. For more insights into our recent achievements and plans under his presidency, read our latest activity report, published at the midpoint of the 2022-2025 mandate : https://lnkd.in/dbJcsKiN Congratulations Mart-Jan!

#Nuclearmedicine, a field where physics, chemistry, and biology converge, continues to captivate scientists and medical practitioners with its cutting-edge imaging technologies and therapeutic advancements. Serge Goldman, a renowned nuclear medicine specialist and researcher, explores this dynamic discipline, highlighting its appeal to those passionate about understanding cellular functions and biochemical processes. In this discussion, Serge Goldman encourages medical students to consider nuclear medicine for its unique integration of diverse scientific knowledge and its direct impact on patient health. Read our latest #publication : "Science, Significance, and Future Perspectives Of Nuclear Medicine - Dialogue with a nuclear medicine specialist" https://lnkd.in/dz8FZD69 An initiative from the Nuclear Medicine Europe Communications Working Group